TABLE 2.

Unadjusted Univariate Comparison of Comorbidities and Preinjury Medications Across Statin and Nonstatin Users

	No PIS Use (n = 224) (%)	PIS Use (n = 71) (%)	P
Comorbidities
Hypercholesterolemia or   hyperlipidemia	1.1	23.9	<0.001*
Hypertension	32.6	74.6	<0.001*
CHF	2.7	9.9	0.010*
Previous MI	8.0	22.5	<0.001*
Previous CABG or stenting	0.7	14.1	<0.001*
Diabetes	14.3	36.6	<0.001*
COPD	6.7	14.1	0.051
Chronic renal disease or   insufficiency	1.8	4.2	0.239
Alcoholism	10.7	4.2	0.098
Liver disease	2.2	2.8	0.778
Smoking	19.6	21.1	0.785
Preinjury medications
ACE inhibitors	5.4	21.1	<0.001
Angiotensin receptor blocker	0.4	5.6	0.003
ASA	10.7	39.4	<0.001
β-Blockers	10.3	47.9	<0.001
Diuretics	3.1	9.9	0.020
Plavix	3.6	14.1	<0.001
Coumadin	5.8	12.7	0.055
Corticosteroids	1.3	4.2	0.133
NSAIDS	4.9	7.0	0.490
Calcium channel blockers	2.2	2.8	0.779
Other direct vasodilators	0.9	2.8	0.222

CHF, congestive heart failure; MI, myocardial infarction; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; ACE, acetycholinesterase inhibitor; ASA, aspirin; NSAIDS, non-steroidal anti-inflammatory drugs.